On the other hand, DPP-4 inhibitors are generally tolerable and safe for use in older people with type 2 diabetes [58, 59] and, as such, they can be an important treatment option in the older/frail population where quality of life is a priority [57, 60]. Here, DPP4 is linked to type 2 diabetes mellitus.